Search research articles
Contact Us
Filters
Showing results (191-200 of 202) with videos related to
Page
of 21
Sort By:
Frontiers in Microbiology
|
February 4, 2021
Comparison of the Multiple Platforms to Identify Various <i>Aeromonas</i> Species
Xiaoli Du, Mengyu Wang, Haijian Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 10, 2026
Olverembatinib-Based Therapy in Patients With Transformed Chronic Myeloid Leukemia in Lymphoid Blast Phase or Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study
Mei Bao, Jian Huang, Zongru Li, et al.
Nature
|
December 13, 2019
A developmental landscape of 3D-cultured human pre-gastrulation embryos
Lifeng Xiang, Yu Yin, Yun Zheng, et al.
Cancer Medicine
|
April 30, 2024
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study
Aijun Liu, Hong Yu, Rui Hou, et al.
Annals of Hematology
|
July 29, 2024
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study
Jingjing Deng, Xiaoqi Qin, Guangyu Ma, et al.
Plos One
|
November 21, 2014
Live birth sex ratio after in vitro fertilization and embryo transfer in China--an analysis of 121,247 babies from 18 centers
Zhiqin Bu, Zi-Jiang Chen, Guoning Huang, et al.
Frontiers in Oncology
|
May 8, 2023
Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China
Zhe Zhuang, Ying Tian, Lei Shi, et al.
Haematologica
|
October 16, 2025
Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation
Mengyao Yuan, Li Zhou, Weiming Li, et al.
Haematologica
|
April 30, 2025
Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia
Xiaoshuai Zhang, Yunfan Yang, Bingcheng Liu, et al.
Annals of Hematology
|
December 19, 2023
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
Huixing Zhou, Yafei Wang, Jiao Chen, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 202) with videos related to
Sort By:
Page
of 21
Frontiers in Microbiology
|
February 4, 2021
Comparison of the Multiple Platforms to Identify Various <i>Aeromonas</i> Species
Xiaoli Du, Mengyu Wang, Haijian Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 10, 2026
Olverembatinib-Based Therapy in Patients With Transformed Chronic Myeloid Leukemia in Lymphoid Blast Phase or Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study
Mei Bao, Jian Huang, Zongru Li, et al.
Nature
|
December 13, 2019
A developmental landscape of 3D-cultured human pre-gastrulation embryos
Lifeng Xiang, Yu Yin, Yun Zheng, et al.
Cancer Medicine
|
April 30, 2024
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study
Aijun Liu, Hong Yu, Rui Hou, et al.
Annals of Hematology
|
July 29, 2024
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study
Jingjing Deng, Xiaoqi Qin, Guangyu Ma, et al.
Plos One
|
November 21, 2014
Live birth sex ratio after in vitro fertilization and embryo transfer in China--an analysis of 121,247 babies from 18 centers
Zhiqin Bu, Zi-Jiang Chen, Guoning Huang, et al.
Frontiers in Oncology
|
May 8, 2023
Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China
Zhe Zhuang, Ying Tian, Lei Shi, et al.
Haematologica
|
October 16, 2025
Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation
Mengyao Yuan, Li Zhou, Weiming Li, et al.
Haematologica
|
April 30, 2025
Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia
Xiaoshuai Zhang, Yunfan Yang, Bingcheng Liu, et al.
Annals of Hematology
|
December 19, 2023
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
Huixing Zhou, Yafei Wang, Jiao Chen, et al.
Page
of 21